Clinical trial

A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

NCT05607693

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2023-04-26

PhasePHASE1

Study timeline

Study start (actual)2023-04-26Date precision: day

Registry last updated2023-05-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Castration-Resistant Prostate Cancerunresolved

Interventions

SHR3680 tabletsDRUG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Mapped research locations

TianjinTianjin Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05607693 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.